Surgery Websites
Transplant Surgery »  Research »  Clinical Research »  Clinical Research Team »  Christopher Ferguson

Christopher Ferguson

Clinical Research Coordinator

Open Popup

While at UCSF, I have been clinical research coodinator on the following clinical trials:


Sandy Feng, MD PhD


A multicenter randomized controlled trial to compare the efficacy of ex-vivo normothermic machine perfusion with static cold storage in human liver transplantation


Donor-Alloantigen Reactive Regulatory T Cell Therapy in Liver Transplantation


Safety of Donor Alloantigen Reactive Tregs (darTregs) to Facilitate Minimization and/or Discontinuation of Immunosuppression in Adult Liver Transplant Recipients


Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients


Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Operational Tolerance Following Liver Transplantation in Adults


A multi-center trial to procure EDTA blood samples from everolimus-treated patients for TDM assay validation and proficiency testing

PEDS trial

Immunosuppression Withdrawal for Pediatric Living-Donor Liver Transplant Recipients: Protocol ITN029ST


A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients: Protocol ITN030ST


A 24 month, randomized, controlled, study to evaluate the efficacy and safety of concentration-controlled everolimus plus reduced tacrolimus compared to standard tacrolimus in recipients of living donor liver transplants


A Prospective Cohort Study of Operationally Tolerant Allograft Recipients

John Roberts, MD

Use of Vital Dyes for Identification of Viability Margins in Solid Organ Transplantation

Chris Freise, MD

An International Randomized Trial to Evaluate the Effectiveness of the Portable Organ Care System (OCS™) Liver for Preserving and Assessing Donor Livers for Transplantation (OCS Liver PROTECT Trial) [future]

Ryutaro Hirose, MD

Baylor HCC-Everolimus

A 36 month multi-center, open label, randomized, comparator study to evaluate the efficacy and safety of everolimus immunosuppression treatment in liver transplantation for hepatocellular carcinoma exceeding Milan criteria.


Chris Freise, MD

Prolong: A Randomized, Placebo-controlled, Prospective, Double-blind, Multicenter Phase 2/3 Study of the Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Recipients of a Donation after Brain Death Kidney Transplant

Sang-Mo Kang, MD

DART trial: Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation: A ONE study Clinical Trial

Peter Stock, MD PhD

CTOT-15: Optimization of NULOJIX (Belatacept) Usage as a Means of Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation

CTOT-16: Steroid and Tacrolimus Avoidance Using NULOJIX® (Belatacept) in Renal Transplantation

Andrew Posselt, MD PhD

Treatment of Type I Diabetes by Alloislet Transplantation into the Gastrointestinal Submucosa

Sandy Feng, MD PhD

A phase 3, randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of QPI-1002 for prevention of Delayed Graft Function in recipients of a donation after brain death older kidney transplant


Garrett Roll, MD

HPV-Gardasil: Immunogenicity of Nonavalent HPV Vaccine Administered Prior To Living Donor Renal Transplantation in Adult Women: A Prospective, Single-Arm, Multi-Center Clinical Trial

Site Directory